Aster DM Quality Care Ltd (ASTERDM) Q1 FY27 Results Analysis: PAT Falls 25%, Revenue Surges 22%

Aster DM Quality Care Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,310.68 Cr (+21.60% YoY) and PAT growth of -68.70% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue grew 21.6% YoY with 82bps margin expansion, but reported PAT was hit by a Rs.114 Cr merger charge. Normalized PAT declined 25% YoY, reflecting greenfield ramp-up costs and wage inflation. The merger with QCIL, effective July 1, 2026, positions the company for synergy benefits, but near-term execution remains key.

Key Investment Insights

Key Positives

• Revenue grew 21.60% YoY to Rs.1,310.68 Cr, strongest quarterly growth in recent quarters
• EBITDA margin before exceptional improved 82 bps YoY to 19.53%, demonstrating operating leverage
• Hospitals & Clinics segment margin expanded 211 bps to 18.70%, the highest Q1 level in recent years
• Labs segment result nearly tripled YoY, margin expanding from 2.82% to 7.04%
• Credit rating upgraded to CRISIL AA+/Stable and ICRA AA/Stable post-merger
• Finance costs nearly flat (+1.43% YoY) despite higher debt, reflecting rating upgrade

Risk Factors

• Reported PAT collapsed 68.70% YoY due to exceptional merger charge of Rs.114.38 Cr
• Normalized PAT declined ~25% YoY, indicating underlying profitability pressure from greenfield ramp-up costs and nurse wage impact
• Employee costs grew 24.33% YoY, outpacing revenue growth of 21.60%, partly due to nurse wage settlement
• Standalone EBITDA margin before exceptional contracted 153 bps YoY to 20.25%, suggesting margin pressure at parent level